Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam

Gene
E CollatzL Gutmann

Abstract

TEM-7 is a novel broad-spectrum beta-lactamase (Bla), selected in vivo, with a resistance profile similar to that of TEM-1 and TEM-2, but extended to ceftazidime (Caz) and aztreonam. Nucleotide sequencing revealed that the TEM-7 gene is almost identical with that of TEM-2. There was 1 bp change which would result in the substitution of Ser (TEM-7) for Arg (TEM-2) in amino acid (aa) position 162 (i.e., aa position 139 of the mature enzyme). This substitution, also found in TEM-101, a spontaneous in vitro derivative of TEM-1 selected on Caz, was assumed to be responsible for the extension of the substrate profile. The assumption was verified by exchange of a DNA fragment, carrying the mutation of the TEM-7-coding gene, with the homologous fragment of the TEM-1-coding gene in pBR322. In the three-dimensional model of class-A Bla [Joris et al., Biochem. J. 250 (1988) 313-324], aa 139 is located at the rim of the groove which contains the active center and adjacent to the evolutionarily conserved BoxV. It is speculated that extra free hydroxyl groups in this area may participate in the stabilization of otherwise non-substrate compounds.

References

Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J G Sutcliffe
Jul 1, 1988·Reviews of Infectious Diseases·L GutmannR Williamson
Aug 1, 1985·Antimicrobial Agents and Chemotherapy·C KliebeB Wiedemann
Jan 24, 1981·Nucleic Acids Research·J MessingP H Seeburg
Jan 1, 1984·The Journal of Antimicrobial Chemotherapy·E E StobberinghC P van Boven

❮ Previous
Next ❯

Citations

Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G A Jacoby
Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A PhilipponP H Lagrange
Jun 15, 1991·Gene·S Goussard, P Courvalin
Sep 1, 1992·International Journal of Antimicrobial Agents·A C Fluit, M R Visser
Dec 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·V SiderakiH F Gilbert
Feb 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sandrine DemanèchePascal Simonet
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·G A Papanicolaou, A A Medeiros
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·G A Jacoby, A A Medeiros
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·L B RiceG A Jacoby
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·C ChanalJ Sirot
Sep 16, 1991·The American Journal of Medicine·F C Tenover
Jun 1, 1991·The Journal of Hospital Infection·P M Bennett, P M Hawkey
Apr 1, 1991·Journal of Chemotherapy·E P Abraham
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·S Goussard, P Courvalin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.